Assessment of Frailty as a Risk Factor for Cardiac and Vascular Surgery

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02224222

Enrollment

300

Registered

2014-08-25

Start date

2014-07-31

Completion date

2020-07-31

Last updated

2019-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases, Heart; Dysfunction Postoperative, Cardiac Surgery, Intellectual Frailty of Aging, Myocardial Infarction, Vascular Diseases

Brief summary

The purpose of this study is to assess the impact of frailty as a multidimensional risk factor on the outcomes of adult cardiac and vascular surgery. For the purpose of defining patient frailty a multimodal questionnaire has been developed including measurement of psychological, socioeconomical, neurological and behavioral aspects. This study also features an investigation of the possible relationship between sudden regional weather changes, individual meteorological susceptibility of the patients and the outcomes of adult cardiac and vascular surgery.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients, 18 years or older, admitted to the hospital for elective cardiac or vascular surgery.

Exclusion criteria

* Not willing to participate. * Pregnant women. * During active psychiatric hospital care. * Patients with defined legal incapability or limited capability. * Congenital or acquired speech impediment and locomotion disability of any kind. * Non-evaluable patient due to communication problems and insufficient clinical information for the judgement of frailty (CFS). * Patients admitted solely for elective surgery of the varices of the lower extremities. * Patients with a transplanted heart.

Design outcomes

Primary

Measure	Time frame
Length of hospital and intensive care unit stay.	Participants will be followed for the duration of hospital stay, an expected average of 2 weeks.

Secondary

Measure	Time frame
Evidence of clinically definite postoperative acute kidney injury and the need for dialysis.	Participants will be followed for the duration of hospital stay, an expected average of 2 weeks.
Evidence of clinically definite postoperative low cardiac output syndrome.	Participants will be followed for the duration of hospital stay, an expected average of 2 weeks.
Evidence of clinically definite postoperative cardiac arrythmias.	Participants will be followed for the duration of hospital stay, an expected average of 2 weeks.
The composite of in-hospital death from any cause.	Participants will be followed for the duration of hospital stay, an expected average of 2 weeks.
Evidence of clinically definite postoperative acute lung injury and the need for mechanical ventilation.	Participants will be followed for the duration of hospital stay, an expected average of 2 weeks.
Evidence of clinically definite postoperative peripheral vascular insufficiency.	Participants will be followed for the duration of hospital stay, an expected average of 2 weeks.
The need for reoperation due to bleeding.	Participants will be followed for the duration of hospital stay, an expected average of 2 weeks.
Evidence of clinically definite postoperative SIRS.	Participants will be followed for the duration of hospital stay, an expected average of 2 weeks.

Countries

Hungary

Outcome results